It may indicate that liver microenvironment plays an active role in reducing the efficacy of BET inhibitors, and co‐inhibition of FGFRs by AZD4547 treatment significantly suppresses tumor growth compared to PLX51107‐treated mice. The gene discussed is DNER; the disease is neoplasm.